December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Emergence of Quinolone Resistance Among Methicillin Sensitive Staphylococcus Aureus Keratitis and Conjunctivitis Isolates
Author Affiliations & Notes
  • FB Marangon
    Bascom Palmer Eye Institute Miami FL
  • D Miller
    Bascom Palmer Eye Institute Miami FL
  • A Romano
    Bascom Palmer Eye Institute Miami FL
  • EC Alfonso
    Bascom Palmer Eye Institute Miami FL
  • Footnotes
    Commercial Relationships   F.B. Marangon, None; D. Miller, None; A. Romano, None; E.C. Alfonso, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 37. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      FB Marangon, D Miller, A Romano, EC Alfonso; Emergence of Quinolone Resistance Among Methicillin Sensitive Staphylococcus Aureus Keratitis and Conjunctivitis Isolates . Invest. Ophthalmol. Vis. Sci. 2002;43(13):37.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:The fluoroquinolones have been used to treat gram-negative bacteria and methicillin sensitive S. aureus keratitis and conjunctivitis pathogens. We investigate the emergence of fluoroquinolone resistance among methicillin sensitive Staphylococcus aureus keratoconjunctivitis isolates Methods:MIC susceptibility profiles for 1182 culture positive patients with S. aureus keratitis and conjunctivitis were analyzed. Historical and current prevalence of emerging quinolone (ciprofloxacin and levofloxacin) resistance for methicillin resistant (MRSA) and methicillin sensitive isolates (MSSA) were monitored. Isolates were further stratified by source. Results:Ciprofloxacin resistance among keratitis and conjunctivitis S aureus isolates during the first six years after its introduction (1990-1995) was 8% and ranged from 3%-11%. Incidence for the most recent 5.5 years (1996-June 2001) was 19.4 %. This represented a 166% increase in ciprofloxacin resistance among keratitis and conjunctivitis S. aureus isolates. Initial baseline prevalence for MSSA isolates was 2% vs 55.8% for MRSA. The current incidence rate for MSSA is 4% vs 82% for MRSA. This represented a 100% increase in resistance for MSSA and 47% for the MRSA. General resistant rate for levofloxacin (2000-June 2001) was 22.9% vs 32.3% for ciprofloxacin during the same time period (p = 0.12). Levofloxacin resistant rate for MSSA was 4.3% vs 11.1% for ciprofloxacin (p = 0.11). Increased resistant among MSSA from baseline for ciprofloxacin was 400%. In MRSA isolates, a higher resistant rate was found for ciprofloxacin (94%) vs levofloxacin (73%), p = 0.024. When both intermediate and resistant isolates were considered, there was no difference (p =0.58.). A higher rate of quinolone resistance was found in keratitis isolates versus those from the conjunctivitis. Conclusion:Quinolone resistance among methicillin sensitive S. aureus keratitis and conjunctivitis isolates is increasing.

Keywords: 587 Staphylococcus • 358 clinical laboratory testing • 449 keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×